INSIGHTS ON PHARMACEUTICAL PRODUCTION

• Technical Considerations For Developing Oral Solids (Part 2)

  What technical considerations should be at the forefront for your oral solids project? This two-part series features four oral solids experts from Pfizer CentreOne’s global network and partner organizations discussing the technical considerations to be aware of. In the second installment of the series, our experts consider the effects of equipment design and different tablet strategies.

• Technical Considerations For Developing Oral Solids (Part 1)

  Navigating your oral solids project from development through commercial manufacture can be a challenging path. In a two-part series, four oral solids experts from Pfizer CentreOne’s global network and partner organizations discuss the technical considerations to be aware of. In this first installment, we look at the importance of technical groundwork and understanding excipients in the early stages of your project.

• Is Your Partner Prepared For Your Scale-Up Challenges?

  Most early-stage companies are not equipped with the means necessary for successful scale-up and commercialization, it is critical you find a partner that can help you overcome the challenges.

• Process Intensification: Getting More From Less

  Intensifying or simplifying your bioprocess can mean more product, shorter manufacturing times, or lower costs –understanding what matters most is key to making the right decisions.

• Tips For Viral Vector Production

  These scalable and cost-efficient processes for GMP manufacturing environments address viral vector manufacturing challenges.

• Cell Growth Performance In Single-Use Bags

  Achieving consistent cell growth is critically important to the biotech industry. To optimize the final drug product output the current industry trends are towards higher cell densities and protein titers.

• Efficient Cleaning-In-Place Methods For Protein-Based Antibody Affinity Chromatography Resins

  This whitepaper discusses cleaning of affinity resins intended for use in the purification of monoclonal antibodies and antibody fragments.

• Recommended Mixing Equipment For Tablet Coatings

  Designed for high-speed powder dispersion, the Ross Solids/Liquid Injection Manifold Mixer is well proven in the preparation of tablet coatings. 

• Quick To Clinic™ for Oral Solid Dose

  In as little as 14 weeks from receiving your small molecule API, you can have your Phase I drug product manufactured, labelled, packaged and delivered to the clinic. That’s 1 month faster than most standard timelines, and includes a one-month stability study.